Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Insulin-Like Growth Factor I, Resistance To
×
Clear all
Filters
2
NCT00924989
2024-11-20
GALACCTIC
Astellas Pharma Inc
Phase 3
Completed
139 enrolled